Related Experiment Video
Updated: Aug 26, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
In vitro activities of tigecycline against the Bacteroides fragilis group
N V Jacobus1, L A McDermott, R Ruthazer
1Department of Medicine, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Abstract:
The in vitro activities of tigecycline were tested against 831 isolates of the Bacteroides fragilis group representing all of the species within the group. On a weight-to-weight basis (8 microg/ml), tigecycline was more active than clindamycin, minocycline, trovafloxacin, and cefoxitin and less active than imipenem or piperacillin-tazobactam against all isolates of the B. fragilis group. Tigecycline geometric mean MICs were statistically higher against B. distasonis than other Bacteroides species (P value of 0.0001).
